Items where Author is "Oxford COVID Vaccine Trial Group, "
![]() | Up a level |
Article
Feng, S, Phillips, DJ, White, T, Sayal, H, Aley, PK, Bibi, S, Dold, C, Fuskova, M, Gilbert, SC, Hirsch, I, Humphries, HE, Jepson, B, Kelly, EJ, Plested, E, Shoemaker, K, Thomas, KM, Vekemans, J, Villafana, TL, Lambe, T, Pollard, AJ , Voysey, M, Oxford COVID Vaccine Trial Group, , Tahmasebi, F and Smith, A (2021) Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. Nature Medicine, 27 (11). pp. 2032-2040. ISSN 1078-8956
Frater, J, Ewer, KJ, Ogbe, A, Pace, M, Adele, S, Adland, E, Alagaratnam, J, Aley, PK, Ali, M, Ansari, MA, Bara, A, Bittaye, M, Broadhead, S, Brown, A, Brown, H, Cappuccini, F, Cooney, E, Dejnirattisai, W, Dold, C, Fairhead, C , Fok, H, Folegatti, PM, Fowler, J, Gibbs, C, Goodman, AL, Jenkin, D, Jones, M, Makinson, R, Marchevsky, NG, Mujadidi, YF, Nguyen, H, Parolini, L, Petersen, C, Plested, E, Pollock, KM, Ramasamy, MN, Rhead, S, Robinson, H, Robinson, N, Rongkard, P, Ryan, F, Serrano, S, Tipoe, T, Voysey, M, Waters, A, Zacharopoulou, P, Barnes, E, Dunachie, S, Goulder, P, Klenerman, P, Screaton, GR, Winston, A, Hill, AVS, Gilbert, SC, Pollard, AJ, Fidler, S, Fox, J, Lambe, T, Oxford COVID Vaccine Trial Group, and Tahmasebi, F (2021) Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial. The lancet. HIV, 8 (8). e474-e485. ISSN 2405-4704